Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Merck & Co Inc (MRK)    
$57.60 0.09 (0.16%) as of 4:30 Fri 4/24


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 2,927,526,000 as of 6/30
Market Cap: 168.63(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $53.43 - $63.03
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Drug Manufacturers - Major

Member Indexes:

    S&P COMPOSITE 1500       DOW JONES COMPOSITE  
    DOW JONES INDUSTRIAL AVERAGE       NYSE COMPOSITE  
    S&P 100       S&P 500  
    MAJOR MARKET  

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  358
Guru Rank Value     : 4.8
Guru Occurances    : 4

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Merck & Co. is a health care company that provides prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. Co.'s operations are comprised of four operating segments: pharmaceutical, which include therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders; animal health, which develops, manufactures and markets animal health products, including vaccines; consumer care, which develops, manufactures and markets over-the-counter, foot care and sun care products; and alliances, which includes Co.'s relationship with AstraZeneca LP.

 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 146,028 303,914 677,406 1,443,542
Total Sell Value $8,553,128 $18,324,342 $40,191,541 $78,492,219
Total People Sold 3 7 9 13
Total Sell Transactions 3 9 20 37
End Date 2015-01-25 2014-10-24 2014-04-25 2013-04-25

   
Records found: 586
  Page 1 of 24  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Harrison William B Jr Director   •       •      –    2015-04-13 4 OE $33.83 $169,150 D/D 5,000 11,400     -
   Deluca Richard R. EVP&Pres, Merck Animal Health   •       •      –    2015-02-23 4 A $58.30 $387,637 D/D 6,649 9,401     -
   Rosenblatt Michael Exec V-P & Chief Med Officer   •       •      –    2015-02-23 4 A $58.30 $291,558 D/D 5,001 30,477     -
   Kuhlik Bruce N Exe V-P & Gen Counsel   •       •      –    2015-02-23 4 A $58.30 $832,641 D/D 14,282 143,671     -
   Schechter Adam H EVP & Pres-Global Human Health   •       •      –    2015-02-23 4 A $58.30 $1,294,143 D/D 22,198 22,198     -
   Ambrose Adele D Sr.V-P & Chief Comuns Officer   •       •      –    2015-02-23 4 A $58.30 $143,535 D/D 2,462 16,845     -
   Frazier Kenneth C Chairman, President & CEO   •       •      –    2015-02-23 4 A $58.30 $4,945,939 D/D 84,836 438,236     -
   Golestani Clark EVP & Chief Info Officer   •       •      –    2015-02-23 4 A $58.30 $85,468 D/D 1,466 9,980     -
   Graddick Weir Mirian M Exe V-P, HR   •       •      –    2015-02-23 4 A $58.30 $652,377 D/D 11,190 106,844     -
   Deese Willie A Exe V-P & Pres. MMD   •       •      –    2015-02-23 4 A $58.30 $510,825 D/D 8,762 114,992     -
   Gerberding Julie L. EVP Strat Comm, Gl Pub Policy   •       •      –    2015-02-23 4 A $58.30 $159,509 D/D 2,736 21,374     -
   Frazier Kenneth C Chairman, President & CEO   •       •      –    2015-02-18 4 OE $31.84 $225,491 D/D 7,082 358,564     -
   Frazier Kenneth C Chairman, President & CEO   •       •      –    2015-02-18 4 AS $58.67 $302,959 D/D (5,164) 353,400     -
   Deese Willie A Exe V-P & Pres. MMD   •       •      –    2015-02-11 4 S $58.56 $7,956,372 D/D (135,864) 106,230 2%     
   Deese Willie A Exe V-P & Pres. MMD   •       •      –    2015-02-11 4 OE $33.49 $5,494,524 D/D 135,864 242,094     -
   Wendell Peter C Director   •       •      –    2015-02-09 4 S $58.76 $293,797 D/D (5,000) 1,000 2%     
   Wendell Peter C Director   •       •      –    2015-02-09 4 OE $33.83 $169,150 D/D 5,000 6,000     -
   Schechter Adam H EVP & Pres-Global Human Health   •       •      –    2015-01-15 4 OE $34.47 $3,055,578 D/D 74,200 74,200     -
   Schechter Adam H EVP & Pres-Global Human Health   •       •      –    2015-01-15 4 AS $62.48 $4,636,224 D/D (74,200) 0 -7%     
   Frazier Kenneth C Chairman, President & CEO   •       •      –    2015-01-09 4 AS $62.47 $552,267 D/D (8,840) 351,482 -7%     
   Frazier Kenneth C Chairman, President & CEO   •       •      –    2015-01-09 4 OE $31.84 $440,240 D/D 12,874 360,322     -
   Gerberding Julie L. EVP Strat Comm, Gl Pub PolicyO   •       –      –    2015-01-01 3 IO $0.00 $0 D/D 0 18,506 1%     
   Frazier Kenneth C Chairman, President & CEO   •       •      –    2014-12-10 4 AS $60.00 $590,760 D/D (9,846) 347,448 -4%     
   Frazier Kenneth C Chairman, President & CEO   •       •      –    2014-12-10 4 OE $31.84 $440,240 D/D 12,874 357,294     -
   Kuhlik Bruce N Exe V-P & Gen Counsel   •       •      –    2014-12-08 4 AS $62.00 $3,100,000 D/D (50,000) 128,467 -7%     

  586 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 24
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed